Brian Cannon

WORK HISTORY

EDUCATION

SKILLS

ABOUT BRIAN CANNON

Brian has been a partner with Quinn Emanuel\'s Silicon Valley office since 2005. He has broad experience with intellectual property matters. He has litigated on behalf of technology companies in patent and commercial law matters, as well as in antitrust and competition law disputes. In addition to a trial practice, Brian advises technology clients with respect to licensing programs, IP rights, portfolio strategy and freedom to operate. He represents clients in matters before the Federal Circuit, the 9th Circuit, and the United States Supreme Court. He was formerly a partner at Shearman & Sterling, and before that, Fish & Neave. He was selected by The Daily Journal in 2011 as one of California’s “Top Biotech Attorneys.”Representative matters include:Complete Genomics Inc v Illumina, No. 19-970-MN (trial member obtaining $334M jury verdict under patents relating to DNA sequencing)Bio-Rad v. 10X, 998 F.3d 13••••21)(argued appeal affirming exclusion order under patents directed to microfluidics)Total Recall Tech v. Oculus VR, No. 19•••44,(9th Cir June 15, 2020)(argued appeal reversing district court decision on contract for virtual reality headset)Stanford v Roche, 563 U.S. 77•••11)(applying Bayh-Dole Act to inventor agreements with universities relating to HIV test kits)Apple v Samsung, 809 F.3d 633 (Fed. Cir. 2015)(reversing judgment of San Jose jury, holding one Apple patent not infringed and two Apple patents invalid)Microsoft v Motorola, 795 F.3d 1024 (9th Cir. 2015)(licensing of standard essential patents)Apple v Motorola, 886 F.Supp.2d 1061 (WD Wisc. 2012)(antitrust and breach of contract matter related to technology licensing)Billups-Rothenberg, Inc. v. ARUP and Bio-Rad, 642 F.3d 1031 (Fed. Cir. 2011)(invalidity and non-infringement of patents directed to genetic testing for iron disorders)